Cullen/Frost Bankers’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-120
Closed -$9.64K 1389
2025
Q4
$9.64K Sell
120
-82
-41% -$6.87K ﹤0.01% 1121
2025
Q3
$19.7K Buy
+202
New +$16.3K ﹤0.01% 947
2024
Q2
Sell
-16
Closed -$1.78K 1238
2024
Q1
$1.78K Buy
+16
New +$1.91K ﹤0.01% 947

Other funds holding ACLS

Cullen/Frost Bankers's ACLS Position: Q1 2026 in Review

Cullen/Frost Bankers sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 120 shares — an estimated $9.64K sold.

Cullen/Frost Bankers first reported a position in ACLS in Q1 2024 and held it in 3 quarters. The position peaked at $19.7K in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Cullen/Frost Bankers reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • Cullen/Frost Bankers sold 120 Axcelis shares in Q1 2026, an estimated $9.64K.
  • Cullen/Frost Bankers first reported a position in Axcelis in Q1 2024 and held it in 3 quarters.
  • Cullen/Frost Bankers's Axcelis position peaked at $19.7K in Q3 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Cullen/Frost Bankers's 13F filing for Q1 2026, filed 5 May 2026.